Cas:942077-83-0 7-Amino-5,6,7,8-tetrahydronaphthalen-2-ol hydrochloride manufacturer & supplier

We serve Chemical Name:7-Amino-5,6,7,8-tetrahydronaphthalen-2-ol hydrochloride CAS:942077-83-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

7-Amino-5,6,7,8-tetrahydronaphthalen-2-ol hydrochloride

Chemical Name:7-Amino-5,6,7,8-tetrahydronaphthalen-2-ol hydrochloride
CAS.NO:942077-83-0
Synonyms:7-Amino-5,6,7,8-tetrahydro-2-naphthalenol hydrochloride (1:1);7-AMINO-5,6,7,8-TETRAHYDRO-NAPHTHALEN-2-OL HYDROCHLORIDE
Molecular Formula:C10H14ClNO
Molecular Weight:199.67700
HS Code:2922299090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:46.25000
Exact Mass:199.07600
LogP:2.71050

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 7-Amino-5,6,7,8-tetrahydro-2-naphthalenol hydrochloride (1:1) chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,7-AMINO-5,6,7,8-TETRAHYDRO-NAPHTHALEN-2-OL HYDROCHLORIDE physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,7-Amino-5,6,7,8-tetrahydro-2-naphthalenol hydrochloride (1:1) Use and application,7-AMINO-5,6,7,8-TETRAHYDRO-NAPHTHALEN-2-OL HYDROCHLORIDE technical grade,usp/ep/jp grade.


Related News: He also mentioned that derivatives of these APIs and lot of other value-added APIs in the same range will also be manufactured at the new facility. ‘Ditellurosalicylsaeureethylester’ manufacturers The European Commission (EC) has approved MSD and Bayer’s Verquvo for the treatment of symptomatic chronic heart failure in patients with reduced ejection fraction. (Z)-methyl 3′-(2-(1-(3,4-dimethylphenyl)-3-methyl-5-oxo-1H-pyrazol-4(5H)-ylidene)hydrazinyl)-2′-hydroxybiphenyl-3-carboxylate suppliers The green light converts the companies’ accelerated approval to a full approval for endometrial cancer that’s not microsatellite instability high (MSI-H) or mismatch repair deficient (dMMR) and for patients whose tumors have progressed following prior treatment. (2R)-2-((3S,4R)-4-methyl-2-oxo-3-(3-oxobutyl)cyclohexyl)propanal vendor & factory.